GYNOSTEL – H 250

Product Description

GYNOSTEL-H 250 Injection contains Hydroxyprogesterone Caproate 250 mg, a long-acting progesterone derivative used to support pregnancy and reduce the risk of preterm birth in women with a history of premature delivery or progesterone deficiency.

This injection helps maintain proper progesterone levels necessary for sustaining pregnancy and promoting uterine stability. It is commonly recommended for women with high-risk pregnancies, helping to ensure continued fetal development and reduce complications associated with premature labor.

Composition

Each vial contains:

• Hydroxyprogesterone Caproate — 250 mg
• Sterile oily base — q.s.

Key Benefits of GYNOSTEL-H 250 Injection

• Helps prevent preterm birth
• Supports high-risk pregnancy management
• Maintains optimal progesterone levels
• Promotes uterine stability
• Reduces risk of premature labor
• Provides long-acting hormonal support
• Supports healthy pregnancy continuation

Mechanism of Action

Hydroxyprogesterone Caproate acts as a long-acting progesterone hormone that helps maintain uterine quiescence and reduces uterine contractions. It supports the uterine lining and promotes hormonal balance required for pregnancy continuation.

Indications

GYNOSTEL-H 250 Injection is indicated for:

• Prevention of preterm birth
• High-risk pregnancy support
• History of premature delivery
• Progesterone deficiency
• Prevention of premature labor
• Pregnancy hormonal support therapy

Dosage & Administration

• Administered intramuscularly under medical supervision.
• Dosage schedule should be determined by the physician based on clinical requirements.

Presentation

• Sterile vial containing Hydroxyprogesterone Caproate 250 mg Injection

Storage Instructions

• Store below 25°C
• Protect from light
• Do not freeze
• Keep out of reach of children

Safety Information

• Use under medical supervision only
• Do not self-administer
• Follow physician’s instructions
• Read the label carefully before use

Why Choose GYNOSTEL-H 250 by Floriwa Labs

• Long-acting progesterone therapy
• Reliable support for high-risk pregnancies
• Manufactured under strict pharmaceutical quality standards
• Trusted formulation from Floriwa Labs
• Designed for safe and effective pregnancy care

About Floriwa Labs

Floriwa Labs, a division of Noxxon Pharmaceuticals Pvt. Ltd., focuses on delivering high-quality pharmaceutical formulations specializing in women’s health, fertility support, and pregnancy care. The company is committed to innovation, safety, and excellence in healthcare manufacturing.